日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Iptacopan in Patients With IgA Nephropathy From East Asia

伊普他考泮治疗东亚IgA肾病患者

Zhang, Hong; Perkovic, Vlado; Barratt, Jonathan; Rizk, Dana V; Rovin, Brad; Trimarchi, Hernán; Maes, Bart; Merkel, Tobias; Desai, Manasi; Ansari, Soudeh; Renfurm, Ronny; Hach, Thomas; Kashihara, Naoki

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy

ALIGN研究的设计和基线特征:一项阿曲生坦治疗IgA肾病患者的随机对照研究

Heerspink, Hiddo J L; Jardine, Meg; Kohan, Donald E; Lafayette, Richard A; Levin, Adeera; Liew, Adrian; Zhang, Hong; Noronha, Irene; Trimarchi, Hernan; Hou, Fan Fan; Renfurm, Ronny; Gray, Todd; Camargo, Marianne; Barratt, Jonathan

Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]

对“ALIGN 研究设计和基线特征,一项阿曲生坦治疗 IgA 肾病患者的随机对照研究”的更正[第 10 卷,第 1 期,2025 年 1 月,第 217-226 页]

Heerspink, Hiddo J L; Jardine, Meg; Kohan, Donald E; Lafayette, Richard A; Levin, Adeera; Liew, Adrian; Zhang, Hong; Noronha, Irene; Trimarchi, Hernan; Hou, Fan Fan; Renfurm, Ronny; Gray, Todd; Camargo, Marianne; Barratt, Jonathan

Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)

一项 2 期随机、安慰剂对照、双盲、适应性、平行组临床研究的研究方案,旨在评估重组 α-1-微球蛋白在开胸心脏手术后急性肾损伤高风险患者中的疗效和安全性(AKITA 试验)。

Mazer, C David; Siadati-Fini, Niloufar; Boehm, Johannes; Wirth, Felix; Myjavec, Andrej; Brown, Craig D; Koyner, Jay L; Boening, Andreas; Engelman, Daniel T; Larsson, Tobias E; Renfurm, Ronny; de Varennes, Benoit; Noiseux, Nicolas; Thielmann, Matthias; Lamy, Andre; Laflamme, Maxime; von Groote, Thilo; Ronco, Claudio; Zarbock, Alexander

One fungus, which genes? Development and assessment of universal primers for potential secondary fungal DNA barcodes.

一种真菌,哪些基因?开发和评估潜在的真菌次级DNA条形码的通用引物

Stielow J B, Lévesque C A, Seifert K A, Meyer W, Iriny L, Smits D, Renfurm R, Verkley G J M, Groenewald M, Chaduli D, Lomascolo A, Welti S, Lesage-Meessen L, Favel A, Al-Hatmi A M S, Damm U, Yilmaz N, Houbraken J, Lombard L, Quaedvlieg W, Binder M, Vaas L A I, Vu D, Yurkov A, Begerow D, Roehl O, Guerreiro M, Fonseca A, Samerpitak K, van Diepeningen A D, Dolatabadi S, Moreno L F, Casaregola S, Mallet S, Jacques N, Roscini L, Egidi E, Bizet C, Garcia-Hermoso D, Martín M P, Deng S, Groenewald J Z, Boekhout T, de Beer Z W, Barnes I, Duong T A, Wingfield M J, de Hoog G S, Crous P W, Lewis C T, Hambleton S, Moussa T A A, Al-Zahrani H S, Almaghrabi O A, Louis-Seize G, Assabgui R, McCormick W, Omer G, Dukik K, Cardinali G, Eberhardt U, de Vries M, Robert V

Novel genera and species of coniothyrium-like fungi in Montagnulaceae (Ascomycota)

山核桃科(子囊菌门)中新的类壳聚糖属和种

G J M Verkley, K Dukik, R Renfurm, M Göker, J B Stielow

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

RUBY-1:一项随机、双盲、安慰剂对照试验,旨在评估新型口服 Xa 因子抑制剂达雷沙班 (YM150) 在急性冠脉综合征后的安全性和耐受性。

Steg, Ph Gabriel; Mehta, Shamir R; Jukema, J Wouter; Lip, Gregory Y H; Gibson, C Michael; Kovar, Frantisek; Kala, Petr; Garcia-Hernandez, Alberto; Renfurm, Ronny W; Granger, Christopher B